Decreased Serum Amyloid A1 as Potential Diagnostic Marker for Gastro-Entero-Pancreatic Neuroendocrine Neoplasms

被引：0
|
作者：
Na, H. [1 ]
Qiyun, T. [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China
来源：
NEUROENDOCRINOLOGY | 2018年 / 106卷
关键词：
exosomes; serum amyloid a1; circulating biomarkers; diagnosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A12
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [21] Complications of surgery for gastro-entero-pancreatic neuroendocrine neoplasias
    Albers, Max B.
    Almquist, Martin
    Bergenfelz, Anders
    Nordenstrom, Erik
    LANGENBECKS ARCHIVES OF SURGERY, 2020, 405 (02) : 137 - 143
  • [22] Surgical management of gastro-entero-pancreatic neuroendocrine tumours
    Arkuszewski, Piotr
    Pasieka, Zbigniew
    Kolomecki, Krzysztof
    Smigielski, Jacek
    Kusinski, Michat
    Hedayati, Masoud
    Srebrzynski, Adam
    Kuzdak, Krzysztof
    PRZEGLAD GASTROENTEROLOGICZNY, 2011, 6 (04): : 252 - 258
  • [23] Chromogranin A as a Marker in the Follow-up of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs). A Systematic Review
    Rossi, R. E.
    Ciafardini, C.
    Conte, D.
    Sciola, V
    Massironi, S.
    NEUROENDOCRINOLOGY, 2018, 106 : 163 - 163
  • [24] Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome
    Panzuto, Francesco
    Merola, Elettra
    Pavel, Marianne Ellen
    Rinke, Anja
    Kump, Patrizia
    Partelli, Stefano
    Rinzivillo, Maria
    Rodriguez-Laval, Victor
    Pape, Ulrich Frank
    Lipp, Rainer
    Gress, Thomas
    Wiedenmann, Bertram
    Falconi, Massimo
    Delle Fave, Gianfranco
    ONCOLOGIST, 2017, 22 (04): : 409 - 415
  • [25] Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms
    Milione, Massimo
    Miceli, Rosalba
    Barretta, Francesco
    Pellegrinelli, Alessio
    Spaggiari, Paola
    Tagliabue, Giovanna
    Centonze, Giovanni
    Paolino, Cinzia
    Mangogna, Alessandro
    Kankava, Ketevani
    Pusceddu, Sara
    Giacomelli, Luca
    Corti, Ambra
    Cotsoglou, Christian
    Mazzaferro, Vincenzo
    Sozzi, Gabriella
    de Braud, Filippo
    Pruneri, Giancarlo
    Anichini, Andrea
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2019, 5 (04): : 217 - 226
  • [26] MicroRNAs and Treatment with Somatostatin Analogs in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Challenges in Personalized Medicine
    Curt, Ana Maria
    Ilie, Ioana Rada Popa
    Cainap, Calin
    Balacescu, Ovidiu
    Ghervan, Cristina
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2020, 29 (04) : 647 - 658
  • [27] THE PROGNOSTIC ROLE OF RADIOMICS IN GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE TUMORS
    Magi, L.
    Polici, M.
    Rinzivillo, M.
    Caruso, D.
    Zerunian, M.
    Masci, B.
    Marasco, M.
    Laghi, A.
    Annibale, B.
    Panzuto, F.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S185 - S185
  • [28] Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic Options
    Merola, Elettra
    Prasad, Vikas
    Pascher, Andreas
    Pape, Ulrich-Frank
    Arsenic, Ruza
    Denecke, Timm
    Fehrenbach, Uli
    Wiedenmann, Bertram
    Pavel, Marianne Ellen
    NEUROENDOCRINOLOGY, 2020, 110 (06) : 517 - 524
  • [29] A neuroendocrine biomarker revolution from monoanalyte to multianalyte biomarkers in non-functioning gastro-entero-pancreatic neuroendocrine neoplasms
    Hoff, Camilla O.
    Manzi, Joao
    Ferreira, Raphaella
    Chauhan, Aman
    Housein, Peter
    Merchant, Nipun
    Livingstone, Alan
    Vianna, Rodrigo
    Abreu, Phillipe
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 203
  • [30] PHOSPHORYLATED HISTONE H3 (PHH3) IS A NOVEL, INTERESTING PROGNOSTIC MARKER IN GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS
    Roggiolani, R.
    Pilozzi, E.
    Nigri, G.
    Rinzivillo, M.
    Ferrone, S.
    Panzuto, F.
    Delle Fave, G.
    Ferrone, C.
    Capurso, G.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E159 - E159
12345